Press Releases Items Per Page 102550 Year None2023202220212020201920182017201620152014201320122011201020092008 September 16, 2021 Revance to Showcase Data from Phase 3 ASPEN-1 Clinical Trial Evaluating Efficacy, Duration of Effect and Safety of DaxibotulinumtoxinA for Injection for Cervical Dystonia at International Parkinson and Movement Disorder Society Virtual Congress 2021 September 10, 2021 Revance Presents Data on the RHA® Collection of Dermal Fillers at the 2021 Virtual Skin of Color Update Meeting September 2, 2021 Revance to Participate in the Wells Fargo Securities Healthcare Conference September 1, 2021 Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery August 5, 2021 Revance Reports Second Quarter 2021 Financial Results, Provides Corporate Update July 29, 2021 Revance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021 May 26, 2021 Revance to Participate in Upcoming Virtual Healthcare Conferences May 26, 2021 Revance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection May 10, 2021 Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update May 3, 2021 Revance to Release First Quarter 2021 Financial Results on Monday, May 10, 2021 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 41 - 50 of 298
